Related Experiment Video

Updated: Apr 20, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

25.4K

Pediatric versus adult cardiomyopathy and heart failure-related hospitalizations: a value-based analysis

Carol A Wittlieb-Weber1, Kimberly Y Lin2, Theoklis E Zaoutis3

  • 1Department of Pediatrics, University of Rochester Medical Center, Rochester, New York.

Journal of Cardiac Failure
|December 3, 2014
PubMed

Insights

Pediatric heart failure hospitalizations show worse outcomes and higher costs compared to adults. Further research is needed to improve cost-effectiveness in pediatric heart failure care.

Area of Science:

  • Pediatric Cardiology
  • Health Services Research
  • Health Economics

Background:

  • Value-based healthcare models are increasingly important for healthcare reimbursement.
  • Limited data exist on the value of pediatric heart failure care.
  • Understanding cost-effectiveness is crucial for optimizing pediatric healthcare.

Purpose of the Study:

  • To compare outcomes and costs of pediatric versus adult hospitalizations for cardiomyopathy and heart failure.
  • To evaluate the implications for value-based care models.

Main Methods:

  • Retrospective analysis of the Kids' Inpatient Database and Nationwide Inpatient Sample.
  • Inclusion of pediatric and adult hospitalizations for cardiomyopathy and heart failure.
  • Comparison of hospitalization duration, mortality, and charges.

Main Results:

  • Pediatric hospitalizations were significantly longer (16.2 days vs 6.8 days) and had higher overall mortality (7.7% vs 5.6%) than adult hospitalizations.
  • Pediatric hospitalizations incurred substantially greater charges ($116,483 vs $40,662).
  • Mortality rates decreased over time for both pediatric and adult populations.

Conclusions:

  • Pediatric heart failure hospitalizations present worse outcomes and higher costs within a value-based framework.
  • More research is essential to understand and improve the cost-effectiveness of pediatric heart failure treatments.
  • Reducing the economic burden of pediatric heart failure on the healthcare system is a key objective.
Abstract

Keywords:
Heart failurecardiomyopathyoutcomes

More Related Videos

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

798
Author Spotlight: Exploring Venous Waveforms in Porcine Models to Tackle Volume Overload in Medicine06:09

Author Spotlight: Exploring Venous Waveforms in Porcine Models to Tackle Volume Overload in Medicine

Published on: January 12, 2024

1.1K

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
724
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
811
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
887
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.4K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K